combined effects of dacarbazine and R715, an antagonist of the bradykinin receptor subtype1.impaired melanoma associated angiogenesis (2006)
- Authors:
- Autor USP: CHAMMAS, ROGER - FM
- Unidade: FM
- Subjects: MELANOMA; VASOS SANGUÍNEOS
- Language: Inglês
- Imprenta:
- Publisher: SBBC/SIMEC
- Publisher place: Búzios
- Date published: 2006
- Source:
- Título: Resumos
- Conference titles: Congresso da Sociedade Brasileira de Biologia Celular
-
ABNT
ANDRADE, Luciana Nogueira de Sousa et al. combined effects of dacarbazine and R715, an antagonist of the bradykinin receptor subtype1.impaired melanoma associated angiogenesis. 2006, Anais.. Búzios: SBBC/SIMEC, 2006. . Acesso em: 14 fev. 2026. -
APA
Andrade, L. N. de S., Pinheiro, M. de C., Nonogaki, S., Nantel, F., Battistini, B., Sirols, P., & Chammas, R. (2006). combined effects of dacarbazine and R715, an antagonist of the bradykinin receptor subtype1.impaired melanoma associated angiogenesis. In Resumos. Búzios: SBBC/SIMEC. -
NLM
Andrade LN de S, Pinheiro M de C, Nonogaki S, Nantel F, Battistini B, Sirols P, Chammas R. combined effects of dacarbazine and R715, an antagonist of the bradykinin receptor subtype1.impaired melanoma associated angiogenesis. Resumos. 2006 ;[citado 2026 fev. 14 ] -
Vancouver
Andrade LN de S, Pinheiro M de C, Nonogaki S, Nantel F, Battistini B, Sirols P, Chammas R. combined effects of dacarbazine and R715, an antagonist of the bradykinin receptor subtype1.impaired melanoma associated angiogenesis. Resumos. 2006 ;[citado 2026 fev. 14 ] - Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy
- Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but non Gal3: Deficient mice
- Use of RNA interference to investigate ADAM23 function and its role breast cancer progression
- F-18-Fluoride PET/CT and Tc-99m-MDP SPECT/CT can detect bone cancer at early stage in rodents
- Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications
- Bases da biologia molecular
- ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis
- Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice
- Epigenetic mechanisms control galectin-3 gene expression along murine melanoma progression
- Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
